Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1111-1117, May 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nahmias, A. J.
Right arrow Articles by Josey, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nahmias, A. J.
Right arrow Articles by Josey, W. E.

Epidemiological Studies Relating Genital Herpetic Infection to Cervical Carcinoma1

André J. Nahmias2, Zuher M. Naib and William E. Josey

Departments of Pediatrics and Preventive Medicine [A. J. N.], Pathology [Z. M. N.], and Gynecology and Obstetrics [W. E. J.], Emory University School of Medicine, Atlanta, Georgia 30303

A large number of epidemiological studies, with a variety of different approaches, have focused in the past decade on the relation of genital herpetic or herpes simplex virus type 2 (HSV-2) infection to cervical cancer. The results reported here of the high frequency of HSV-2 antibodies in young women (≤21 years) with cervical carcinoma in situ and in women with dysplasia or carcinoma in situ, matched for various sexual attributes to control women, provide support for a causal relation. Nevertheless, the various laboratory, histopathological, and statistical problems associated with all epidemiological studies conducted to date do not yet permit a firm conclusion to be reached as to the etiological role of the genital virus in cervical carcinogenesis. With improvement in laboratory technology, such as the use of herpes-related cancer antigens or purified HSV-2 typespecific antigens, and with the possible development of protective HSV-2 vaccines, the application of epidemiological approaches will probably be necessary to provide the most finite evidence of causality.

1 Presented at the International Symposium on Human Tumors Associated with Herpesviruses, March 26 to 28, 1973, Bethesda, Md. Supported by Grant VC-71V from the American Cancer Society and Grant CA-11433 from the National Cancer Institute, NIH, USPHS.

2 Presented by.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.